Loading...
Please wait, while we are loading the content...
Similar Documents
Glycoprotein IIb/IIIa inhibitors: do they still have a role?
| Content Provider | Semantic Scholar |
|---|---|
| Author | Bhatt, Deepak L. |
| Copyright Year | 2011 |
| Abstract | Compared with aspirin plus unfractionated heparin, the addition of intravenous glycoprotein IIb/IIIa inhibitors (GPIs) represented a major advance in percutaneous coronary intervention (PCI). The benefits were particularly notable in high-risk patients, such as those with acute coronary syndromes or |
| File Format | PDF HTM / HTML |
| DOI | 10.1016/j.jacc.2010.10.031 |
| PubMed reference number | 21371636 |
| Journal | Medline |
| Volume Number | 57 |
| Issue Number | 10 |
| Alternate Webpage(s) | http://www.onlinejacc.org/content/accj/57/10/1200.full.pdf |
| Alternate Webpage(s) | https://doi.org/10.1016/j.jacc.2010.10.031 |
| Journal | Journal of the American College of Cardiology |
| Language | English |
| Access Restriction | Open |
| Content Type | Text |
| Resource Type | Article |